Case Studies Q. You are a government officer under the central government. In the pursuit of improved public services, the central government is implementing a digital transformation initiative, involving the collection and analysis of citizens' data. You are vested with the responsibility of implementing the digital transformative initiative of the central government. During the implementation process, concerns were raised about the right to privacy and the potential misuse of personal data by private tech firms. While the initiative promises socio-economic development, questions about fair benefits distribution and societal inequalities have emerged due to a lack of clear regulations. A. What are the ethical challenges that you face as an officer in charge of the digital transformation initiative? B. How would you balance the competing interests of the government, the citizens, and the private tech firms in this situation?

Case Study: You are the Managing Director of "XYZ Biotech", a rapidly growing pharmaceutical firm based in India, with operations in several developing countries. Your company has recently developed a breakthrough mRNA-based vaccine for a rapidly mutating tropical disease affecting large sections of the population in Sub-Saharan Africa and parts of South Asia. The vaccine has demonstrated 94% efficacy in Phase III clinical trials and has the potential to save thousands of lives. However, the vaccine is expensive to manufacture, requiring specialized cold-chain storage, and proprietary biotechnology inputs licensed from international partners. The pricing strategy proposed by your Board is to recoup R&D investments and generate profit by pricing the vaccine at Rs. 3000 per dose, which makes it unaffordable for many low-income populations in target regions. Meanwhile, several NGOs, global health organizations, and even a few governments are urging you to waive your patent rights, or adopt tiered pricing to allow cheaper versions or voluntary licensing for public-sector manufacture. You are also under pressure from investors, who expect high returns due to the innovation. Some stakeholders suggest cutting costs by outsourcing trials to countries with weaker regulatory standards, while others propose delaying access in poorer countries to focus on wealthier clients first. Your own conscience is conflicted—you believe in public health as a right, but also have obligations to shareholders, employees, and long-term sustainability of the firm. a) Identify and discuss the ethical issues involved in this case. b) What would be your immediate response to the situation described above? c) If a global health coalition asks for voluntary licensing of your vaccine, how would you respond both ethically and strategically? d) As a conscientious public-spirited executive, suggest a balanced strategy that ensures innovation, affordability, and ethical integrity.

Case Study Dr. Ananya Rao is a senior drug regulator in a state where several pharmaceutical manufacturing units produce low-cost medicines, including paediatric cough syrups, for both domestic use and export. These medicines are widely used by economically weaker sections due to their affordability. Recently, reports emerged that a batch of cough syrups manufactured by a local company was linked to the deaths of several children after consumption. Preliminary investigations indicated the presence of toxic contaminants due to the use of substandard raw materials and poor quality control. International media coverage has raised serious concerns about India’s pharmaceutical regulatory standards, affecting the country’s reputation as the “pharmacy of the world.” The manufacturing company claims that it complied with existing regulations and argues that stricter enforcement and frequent inspections would increase production costs, making medicines unaffordable for the poor and harming export competitiveness. Some political and industry stakeholders have informally urged Dr. Rao to avoid drastic action such as suspension of licenses, citing potential job losses, investor backlash, and diplomatic sensitivities. At the same time, families of the affected children are demanding accountability, criminal prosecution, and compensation. Public trust in the healthcare system and drug safety mechanisms is visibly eroding. Questions 1.Discuss the ethical dilemma between affordability of medicines, industrial growth, and the principle of ‘non malfiance’ in Bio ethics ethics. 2.What options are available to Dr. Ananya Rao in responding to this crisis? Evaluate the ethical merits and limitations of each option. 3.What course of action should Dr. Rao adopt to uphold medical ethics, accountability, and public interest while ensuring long-term credibility of the health system? Justify your answer.

In the religious land of India, there exists the exploitative custom of sexual slavery known as the Jogini system (a local variation of the Devadasi system) which involves marrying young girls to a deity. This social evil has resisted the legal measures aimed at curbing it till date, despite having been prohibited as per the Devadasi (Prohibition of Dedication) Act. You are posted as a District Magistrate and you get to know about such practice taking place in the area of your jurisdiction. Two Dalit girls have been confined and being prepared for dedication to God as devadasis. The children are forced into becoming Devadasis by their own parents because girls are their only source of income in most cases. In a society where a girl child is often considered a liability, turning them into Devadasis is how patriarchy works to transform them into assets. You also get to know of child prostitution being practiced in the name of Devadasi. (a) What course of action will you take in such a scenario? (b) What are the issues involved in banning the practice of Devadasi system, in spite of the laws already present against it?

Case Study You are the District Election Officer (DEO) in a politically sensitive district in India, where a local election is taking place. Just days before the election, a deepfake video of one of the leading candidates emerges, showing them making controversial comments about a particular community. The video is quickly shared across social media platforms, leading to widespread misinformation, increased tension between local communities, and several violent protests. The police are struggling to control the situation, and the election authorities are under immense pressure to address the issue. As the DEO, you are tasked with managing the situation effectively. You must coordinate with local law enforcement, social media companies, and other stakeholders to contain the spread of the video and restore peace in the district. You also need to ensure that such incidents are prevented in the future while safeguarding the integrity of the election process. 1. What are the stakeholders involved in this situation? 2. What are the laws in place to curb deepfake? 3. What steps will you take to stop the spread of the deep fake video and calm the situation?